Epidemiology and susceptibility of pathogens from SMART 2011–12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections
Author(s) -
İftihar Köksal,
Gürdal Yılmaz,
Serhat Ünal,
Pınar Zarakolu,
Volkan Korten,
Lütfiye Mülazımoğlu,
Fehmı Tabak,
Bilgül Mete,
Vildan Avkan Oğuz,
Zeynep Gülay,
Emine Alp,
Robert E. Badal,
Sibylle Lob
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkw574
Subject(s) - amikacin , imipenem , medicine , ertapenem , microbiology and biotechnology , klebsiella pneumoniae , antimicrobial , antibiotics , biology , antibiotic resistance , escherichia coli , biochemistry , gene
To describe the epidemiology and susceptibility of pathogens (including ESBL producers) from hospital-acquired (HA) versus community-acquired (CA) urinary tract infections (UTIs) and ICU- versus non-ICU-associated intra-abdominal infections (IAIs) in Turkey as a part of the SMART study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom